Regulation of the cancer cell membrane lipid composition by NaCHOleate: Effects on cell signaling and therapeutical relevance in glioma

Biochimica et Biophysica Acta - Biomembranes

Volumn 1838, Issue 6, 2014, Pages 1619-1627

  Lladó, Victoria ^a   López, David J ^a   Ibarguren, Maitane ^a   Alonso, María ^a   Soriano, Joan B ^b   Escribá, Pablo V ^a   Busquets, Xavier ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Epidemiology and Clinical Research   (Spain)

Author keywords

Brain cancer; Cancer therapy; Cell membrane; Membrane lipid therapy; REMBRANDT; Sphingomyelin

Indexed keywords

BRAIN CANCER; CANCER THERAPY; CELL MEMBRANE; MEMBRANE LIPID THERAPY; REMBRANDT; SPHINGOMYELIN;

ANIMALS; CELL MEMBRANE; GLIOMA; HUMANS; MEMBRANE LIPIDS; OLEIC ACIDS; SIGNAL TRANSDUCTION;

EID: 84899421131     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.01.027     Document Type: Review

References (86)

1. A.A. Spector, and M.A. Yorek Membrane lipid composition and cellular function J. Lipid Res. 26 1985 1015 1035
2. R. Luostarinen, M. Boberg, and T. Saldeem Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death Atherosclerosis 99 1993 187 193
3. P.V. Escriba, J.M. Sanchez-Dominguez, R. Alemany, J.S. Perona, and V. Ruiz-Gutiérrez Alteration of lipids, G proteins, and PKC in cell membranes of elderly hypertensives Hypertension 41 2003 176 182
4. R.P. Mason, and R.F. Jacob Membrane microdomains and vascular biology: emerging role in atherogenesis Circulation 107 2003 2270 2273
5. J.S. Perona, and V. Ruiz-Gutierrez Triacylglycerol molecular species are depleted to different extents in the myocardium of spontaneously hypertensive rats fed two oleic acid-rich oils Am. J. Hypertens. 18 2005 72 80
6. A. Rashid, E.S. Pizer, M. Moga, L.Z. Milgraum, M. Zahurak, G.R. Pasternack, F.P. Kuhajda, and S.R. Hamilton Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia Am. J. Pathol. 150 1997 201 208
7. J.V. Swinnen, F. Vanderhoydonc, A.A. Elgamal, M. Eelen, I. Vercaeren, S. Joniau, H. Van Poppel, L. Baert, K. Goossens, W. Heyns, and G. Verhoeven Selective activation of the fatty acid synthesis pathway in human prostate cancer Int. J. Cancer 88 2000 176 179
8. F.P. Kuhajda Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 66 2006 5977 5980
9. N. Azordegan, V. Fraser, K. Le, L.M. Hillyer, D.W. Ma, G. Fischer, and M.H. Moghadasian Carcinogenesis alters fatty acid profile in breast tissue Mol. Cell. Biochem. 374 2013 223 232
10. L. Riboni, R. Campanella, R. Bassi, R. Villani, S.M. Gaini, F. Martinelli-Boneschi, P. Viani, and G. Tettamanti Ceramide levels are inversely associated with malignant progression of human glial tumors Glia 39 2002 105 113
11. S. Birkle, G. Zeng, L. Gao, R.K. Yu, and J. Aubry Role of tumor-associated gangliosides in cancer progression Biochimie 85 2003 455 463
12. S. Hettmer, S. Ladisch, and K. Kaucic Low complex ganglioside expression characterizes human neuroblastoma cell lines Cancer Lett. 225 2005 141 149
13. M.F. Mulas, A. Mandas, C. Abete, S. Dessì, A. Mocali, and F. Paoletti Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells Hematol. Rep. 3 2011 e19
14. N. Bartke, and Y.A. Hannun Bioactive sphingolipids: metabolism and function J. Lipid Res. 50 2009 S91 S96 (Suppl.)
15. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J. 23 2004 33 44
16. F.G. Tafesse, P. Ternes, and J.C. Holthuis The multigenic sphingomyelin synthase family J. Biol. Chem. 281 2006 29421 29425
17. G. Barcelo-Coblijn, M.L. Martin, R.F. de Almeida, M.A. Noguera-Salvà, A. Marcilla-Etxenike, F. Guardiola-Serrano, A. Lüth, B. Kleuser, J.E. Halver, and P.V. Escribá Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy Proc. Natl. Acad. Sci. U. S. A. 108 2011 19569 19574
18. S.J. Singer, and G.L. Nicolson The fluid mosaic model of the structure of cell membranes Science 175 1972 720 731
19. D.M. Engelman Membranes are more mosaic than fluid Nature 438 2005 578 580
20. G. van Meer, and A.I. de Kroon Lipid map of the mammalian cell J. Cell Sci. 124 2011 5 8
21. M. Ibarguren, D.J. López, J.A. Encinar, J.M. González-Ros, X. Busquets, and P.V. Escribá Partitioning of liquid-ordered/liquid- disordered membrane microdomains induced by the fluidifying effect of 2-hydroxylated fatty acid derivatives Biochim. Biophys. Acta 1828 2013 2553 2563
22. D. Lingwood, and K. Simons Lipid rafts as a membrane-organizing principle Science 327 2010 46 50
23. A. Yamaji-Hasegawa, and M. Tsujimoto Asymmetric distribution of phospholipids in biomembranes Biol. Pharm. Bull. 29 2006 1547 1553
24. P.R. Cullis, and B. de Kruijff Lipid polymorphism and the functional roles of lipids in biological membranes Biochim. Biophys. Acta 559 1979 399 420
25. P. Yeagle The Structure of Biological Membranes second ed. 2010 CRC Press Boca Raton, London
26. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
27. L.J. Pike Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function J. Lipid Res. 47 2006 1597 1598
28. B.M. Castro, R.F. de Almeida, L.C. Silva, A. Fedorov, and M. Prieto Formation of ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative multiprobe approach Biophys. J. 93 2007 1639 1650
29. V. Luzzati X-ray diffraction studies of lipid-water systems D. Chapman, Biological Membranes 1968 Academic Press London 71 123
30. D. Piomelli, G. Astarita, and R. Rapaka A neuroscientist's guide to lipidomics Nat. Rev. Neurosci. 8 2007 743 754
31. P. Oh, and J.E. Schnitzer Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default Mol. Biol. Cell 12 2001 685 698
32. J. Li, B. Xiang, W. Su, X. Zhang, Y. Huang, and L. Ma Agonist-induced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-G beta gamma complex on membrane is required for GRK2 function in vivo J. Biol. Chem. 278 2003 30219 30226
33. O. Vogler, J. Casas, D. Capó, T. Nagy, G. Borchert, G. Martorell, and P.V. Escribá The Gbetagamma dimer drives the interaction of heterotrimeric Gi proteins with nonlamellar membrane structures J. Biol. Chem. 279 2004 36540 36545
34. J. Martinez, O. Vogler, J. Casas, F. Barceló, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P.G. Kasprzyk, S. Terés, C. Saus, and P.V. Escribá Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval Mol. Pharmacol. 67 2005 531 540
35. J. Giorgione, R.M. Epand, C. Buda, and T. Farkas Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C Proc. Natl. Acad. Sci. U. S. A. 92 1995 9767 9770
36. F.M. Goñi, and A. Alonso Structure and functional properties of diacylglycerols in membranes Prog. Lipid Res. 38 1999 1 48
37. T.G. Kutateladze Molecular analysis of protein-phosphoinositide interactions Curr. Top. Microbiol. Immunol. 362 2012 111 126
38. M. Miyaji, Z.X. Jin, S. Yamaoka, R. Amakawa, S. Fukuhara, S.B. Sato, T. Kobayashi, N. Domae, T. Mimori, E.T. Bloom, T. Okazaki, and H. Umehara Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis J. Exp. Med. 202 2005 249 259
39. V. Llado, A. Gutierrez, J. Martínez, J. Casas, S. Terés, M. Higuera, A. Galmés, C. Saus, J. Besalduch, X. Busquets, and P.V. Escribá Minerval induces apoptosis in Jurkat and other cancer cells J. Cell. Mol. Med. 14 2010 659 670
40. F. Mollinedo, J. de la Iglesia-Vicente, C. Gajate, A. Estella-Hermoso de Mendoza, J.A. Villa-Pulgarin, M. de Frias, G. Roué, J. Gil, D. Colomer, M.A. Campanero, and M.J. Blanco-Prieto In vitro and in vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts Clin. Cancer Res. 16 2010 2046 2054
41. M.D. Resh Covalent lipid modifications of proteins Curr. Biol. 23 2013 R431 R435
42. P.C. van der Wel, T. Pott, S. Morein, D.V. Greathouse, R.E. Koeppe II, and J.A. Killian Tryptophan-anchored transmembrane peptides promote formation of nonlamellar phases in phosphatidylethanolamine model membranes in a mismatch-dependent manner Biochemistry 39 2000 3124 3133
43. S. Funari, J. Prades, P.V. Escribá, and F. Barceló Farnesol and geranylgeraniol modulate the structural properties of phosphatidylethanolamine model membranes Mol. Membr. Biol. 22 2005 303 311
44. S. Funari, F. Barcelo, and P.V. Escribá Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes J. Lipid Res. 44 2003 567 575
45. J. Prades, S. Funari, P.V. Escribá, and F. Barceló Effects of unsaturated fatty acids and triacylglycerols on phosphatidylethanolamine membrane structure J. Lipid Res. 44 2003 1720 1727
46. Q. Yang, R. Alemany, J. Casas, K. Kitajka, S.M. Lanier, and P.V. Escribá Influence of the membrane lipid structure on signal processing via G protein-coupled receptors Mol. Pharmacol. 68 2005 210 217
47. J.M. Martin-Moreno, W.C. Willett, L. Gorgojo, J.R. Banegas, F. Rodriguez-Artalejo, J.C. Fernandez-Rodriguez, P. Maisonneuve, and P. Boyle Dietary fat, olive oil intake and breast cancer risk Int. J. Cancer 58 1994 774 780
48. S.R. Shaikh Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts J. Nutr. Biochem. 23 2012 101 105
49. T.R. Triton, and G. Yee The anticancer agent adriamycin can be actively cytotoxic without entering cells Science 217 1982 248 250
50. P.V. Escriba, M. Sastre, and J.A. García-Sevilla Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures Proc. Natl. Acad. Sci. U. S. A. 92 1995 7595 7599
51. P.V. Escriba, P. Morales, and A. Smith Membrane phospholipid reorganization differentially regulates metallothionein and heme oxygenase by heme-hemopexin DNA Cell Biol. 21 2002 355 364
52. J. Michaeli, X. Busquets, I. Orlow, A. Younes, D. Colomer, P.A. Marks, R.A. Rifkind, and R.N. Kolesnick A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis J. Biol. Chem. 267 1992 23463 23466
53. V. Jendrossek, and R. Handrick Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers Curr. Med. Chem. Anticancer Agents 3 2003 343 353
54. S.M. Ali, A.R. Khan, M.U. Ahmad, P. Chen, S. Sheikh, and I. Ahmad Synthesis and biological evaluation of gemcitabine-lipid conjugate (NEO6002) Bioorg. Med. Chem. Lett. 15 2005 2571 2574
55. R.A. Siddiqui, M. Zerouga, M. Wu, A. Castillo, K. Harvey, G.P. Zaloga, and W. Stillwell Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells Breast Cancer Res. 7 2005 R645 R654
56. K.A. Harvey, Z. Xu, P. Whitley, V.J. Davisson, and R.A. Siddiqui Characterization of anticancer properties of 2,6-diisopropylphenol- docosahexaenoate and analogues in breast cancer cells Bioorg. Med. Chem. 18 2010 1866 1874
57. R. Willumeit, M. Kumpugdee, S.S. Funari, K. Lohner, B.P. Navas, K. Brandenburg, S. Linser, and J. Andrä Structural rearrangement of model membranes by the peptide antibiotic NK-2 Biochim. Biophys. Acta 1669 2005 125 134
58. S. Drechsler, and J. Andra Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes J. Bioenerg. Biomembr. 43 2011 275 285
59. J. Prades, R. Alemany, J.S. Perona, S.S. Funari, O. Vögler, V. Ruiz-Gutiérrez, P.V. Escribá, and F. Barceló Effects of 2-hydroxyoleic acid on the structural properties of biological and model plasma membranes Mol. Membr. Biol. 25 2008 46 57
60. M.L. Martin, G. Liebisch, S. Lehneis, G. Schmitz, M. Alonso-Sande, J. Bestard-Escalas, D.H. Lopez, J.M. García-Verdugo, M. Soriano-Navarro, X. Busquets, P.V. Escribá, and G. Barceló-Coblijn Sustained activation of sphingomyelin synthase by 2-hydroxyoleic acid induces sphingolipidosis in tumor cells J. Lipid Res. 54 2013 1457 1465
61. M.L. Martin, G. Barcelo-Coblijn, R.F. de Almeida, M.A. Noguera-Salvà, S. Terés, M. Higuera, G. Liebisch, G. Schmitz, X. Busquets, and P.V. Escribá PV The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid Biochim. Biophys. Acta 1828 2013 1405 1413
62. S. Teres, V. Llado, M. Higuera, G. Barceló-Coblijn, M.L. Martin, M.A. Noguera-Salvà, A. Marcilla-Etxenike, J.M. García-Verdugo, M. Soriano-Navarro, C. Saus, U. Gómez-Pinedo, X. Busquets, and P.V. Escribá 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy Proc. Natl. Acad. Sci. U. S. A. 109 2012 8489 8494
63. K. Simons, and D. Toomre Lipid rafts and signal transduction Nat. Rev. Mol. Cell Biol. 1 2000 31 39
64. R.F. de Almeida, A. Fedorov, and M. Prieto Sphingomyelin/ phosphatidylcholine/cholesterol phase diagram: boundaries and composition of lipid rafts Biophys. J. 85 2003 2406 2416
65. R.F. de Almeida, L.M. Loura, A. Fedorov, and M. Prieto Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study J. Mol. Biol. 346 2005 1109 1120
66. F. Barcelo, J. Prades, S.S. Funari, J. Frau, R. Alemany, and P.V. Escribá The hypotensive drug 2-hydroxyoleic acid modifies the structural properties of model membranes Mol. Membr. Biol. 21 2004 261 268
67. H. Brenner, S. Francisci, R. de Angelis, R. Marcos-Gragera, A. Verdecchia, G. Gatta, C. Allemani, L. Ciccolallo, M. Coleman, and M. Sant Long-term survival expectations of cancer patients in Europe in 2000-2002 Eur. J. Cancer 45 2009 1028 1041
68. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 2005 987 996
69. J. Martinez, A. Gutierrez, J. Casas, V. Lladó, A. López-Bellan, J. Besalduch, A. Dopazo, and P.V. Escribá The repression of E2F-1 is critical for the activity of Minerval against cancer J. Pharmacol. Exp. Ther. 315 2005 466 474
70. V. Lladó, S. Teres, M. Higuera, R. Alvarez, M.A. Noguera-Salvá, J.E. Halver, P.V. Escribá, and X. Busquets Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid Proc. Natl. Acad. Sci. U. S. A. 106 2009 13754 13758
71. A. Marcilla-Etxenike, M.L. Martin, M.A. Noguera-Salvà, J.M. García-Verdugo, M. Soriano-Navarro, I. Dey, P.V. Escribá, and X. Busquets 2-Hydroxyoleic acid induces ER stress and autophagy in various human glioma cell lines PLoS One 7 2012 e48235
72. A. Jerome-Morais, H.R. Rahn, S.S. Tibudan, and M.F. Denning Role for protein kinase C-alpha in keratinocyte growth arrest J. Invest. Dermatol. 129 2009 2365 2375
73. B.C. Widemann, R.J. Arceci, N. Jayaprakash, E. Fox, P. Zannikos, W. Goodspeed, A. Goodwin, J.J. Wright, S.M. Blaney, P.C. Adamson, and F.M. Balis Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group Pediatr. Blood Cancer 56 2011 226 233
74. A.T. Parsa, and E.C. Holland Cooperative translational control of gene expression by Ras and Akt in cancer Trends Mol. Med. 10 2004 607 613
75. K.S. Kelly-Spratt, J. Philipp-Staheli, K.E. Gurley, K. Hoon-Kim, S. Knoblaugh, and C.J. Kemp Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer Oncogene 28 2009 3652 3662
76. R.G. Tatevossian, A.R. Lawson, T. Forshew, G.F. Hindley, D.W. Ellison, and D. Sheer MAPK pathway activation and the origins of pediatric low-grade astrocytomas J. Cell. Physiol. 222 2010 509 514
77. A phase I/IIA study of Minerval in adult patients with advanced solid tumours Hhttp://www.clinicaltrials.gov
78. H.A. Hirsch, D. Iliopoulos, A. Joshi, Y. Zhang, S.A. Jaeger, M. Bulyk, P.N. Tsichlis, X. Shirley Liu, and K.A. Struhl Transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases Cancer Cell 17 2010 348 361
79. M. Crous-Bou, G. Rennert, R. Salazar, F. Rodriguez-Moranta, H.S. Rennert, F. Lejbkowicz, L. Kopelovich, S.M. Lipkin, S.B. Gruber, and V. Moreno Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer Mutagenesis 27 2012 169 176
80. M. Hilvo, C. Denkert, L. Lehtinen, B. Müller, S. Brockmöller, T. Seppänen-Laakso, J. Budczies, E. Bucher, L. Yetukuri, S. Castillo, E. Berg, H. Nygren, M. Sysi-Aho, J.L. Griffin, O. Fiehn, S. Loibl, C. Richter-Ehrenstein, C. Radke, T. Hyötyläinen, O. Kallioniemi, K. Iljin, and M. Oresic Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression Cancer Res. 71 2011 3236 3245
81. H. Ying, J. Lv, T. Ying, S. Jin, J. Shao, L. Wang, H. Xu, B. Yuan, and Q. Yang Gene-gene interaction network analysis of ovarian cancer using TCGA data J. Ovarian Res. 6 2013 88
82. REMBRANDT Homepage. Institute, N. C. http://rembrandt.nci.nih.gov 2005 (Accessed May 15th 2013)
83. S. Madhavan, J.C. Zenklusen, Y. Kotliarov, H. Sahni, H.A. Fine, and K. Buetow REMBRANDT: helping personalized medicine become a reality through integrative translational research Mol. Cancer Res. 7 2009 157 167
84. D.W. Hosmer, S. Lemeshow, and S. May Applied Survival Analysis: Regression Modeling of Time to Event Data 2008 Wiley Interscience Hoboken, New Jersey, USA
85. J. Wang, H. Wang, Z. Li, Q. Wu, J.D. Lathia, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich c-Myc is required for maintenance of glioma cancer stem cells PLoS One 3 2008 e3769
86. M. Maruno, J.S. Kovach, P.J. Kelly, and T. Yanagihara Distribution of endogenous tumour necrosis factor alpha in gliomas J. Clin. Pathol. 50 1997 559 562